Cargando…

Clinicopathological Analysis of 21 Thymic Neuroendocrine Tumors

BACKGROUND: Thymic neuroendocrine carcinomas (NECs) are uncommon, for which there is no established information available because of a limited number of epidemiological study in Asia. METHODS: We reviewed 21 cases of surgically resected thymic NECs, and evaluated their pathological and clinical feat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Soomin, Lee, Jae Jun, Ha, Sang Yun, Sung, Chang Ohk, Kim, Jhingook, Han, Joungho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pathologists and The Korean Society for Cytopathology 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479770/
https://www.ncbi.nlm.nih.gov/pubmed/23110006
http://dx.doi.org/10.4132/KoreanJPathol.2012.46.3.221
_version_ 1782247460138123264
author Ahn, Soomin
Lee, Jae Jun
Ha, Sang Yun
Sung, Chang Ohk
Kim, Jhingook
Han, Joungho
author_facet Ahn, Soomin
Lee, Jae Jun
Ha, Sang Yun
Sung, Chang Ohk
Kim, Jhingook
Han, Joungho
author_sort Ahn, Soomin
collection PubMed
description BACKGROUND: Thymic neuroendocrine carcinomas (NECs) are uncommon, for which there is no established information available because of a limited number of epidemiological study in Asia. METHODS: We reviewed 21 cases of surgically resected thymic NECs, and evaluated their pathological and clinical features. RESULTS: It showed male predominance (male/female ratio, 15/6) with wide age range from 20 to 72 years (mean age, 49 years). All 21 cases were divided into two types according to the World Health Organization criteria: atypical carcinoid (n=18) and large cell NEC (n=3). Three cases of atypical carcinoid (AC) were associated with ectopic Cushing's syndrome. All the patients (3/3) with large cell NEC (3/3) and 16.7% (3/18) of those with AC died of tumor progression. Common sites of metastasis included lung, lymph node, brain, lumbar spine, mediastinum, bone, and liver. CONCLUSIONS: In conclusion, thymic neuroendocrine tumors carry a poor prognosis. Regarding the tumor classification, our results showed that a vast majority of carcinoids in the thymus correspond to ACs. In addition, our results also indicate that typical carcinoid is a very rare entity. Some cases of AC exhibited a large size, solid pattern and they showed aggressive clinical behavior, which highlights the spectrum of histologic appearances of thymic NECs.
format Online
Article
Text
id pubmed-3479770
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher The Korean Society of Pathologists and The Korean Society for Cytopathology
record_format MEDLINE/PubMed
spelling pubmed-34797702012-10-29 Clinicopathological Analysis of 21 Thymic Neuroendocrine Tumors Ahn, Soomin Lee, Jae Jun Ha, Sang Yun Sung, Chang Ohk Kim, Jhingook Han, Joungho Korean J Pathol Original Article BACKGROUND: Thymic neuroendocrine carcinomas (NECs) are uncommon, for which there is no established information available because of a limited number of epidemiological study in Asia. METHODS: We reviewed 21 cases of surgically resected thymic NECs, and evaluated their pathological and clinical features. RESULTS: It showed male predominance (male/female ratio, 15/6) with wide age range from 20 to 72 years (mean age, 49 years). All 21 cases were divided into two types according to the World Health Organization criteria: atypical carcinoid (n=18) and large cell NEC (n=3). Three cases of atypical carcinoid (AC) were associated with ectopic Cushing's syndrome. All the patients (3/3) with large cell NEC (3/3) and 16.7% (3/18) of those with AC died of tumor progression. Common sites of metastasis included lung, lymph node, brain, lumbar spine, mediastinum, bone, and liver. CONCLUSIONS: In conclusion, thymic neuroendocrine tumors carry a poor prognosis. Regarding the tumor classification, our results showed that a vast majority of carcinoids in the thymus correspond to ACs. In addition, our results also indicate that typical carcinoid is a very rare entity. Some cases of AC exhibited a large size, solid pattern and they showed aggressive clinical behavior, which highlights the spectrum of histologic appearances of thymic NECs. The Korean Society of Pathologists and The Korean Society for Cytopathology 2012-06 2012-06-22 /pmc/articles/PMC3479770/ /pubmed/23110006 http://dx.doi.org/10.4132/KoreanJPathol.2012.46.3.221 Text en © 2012 The Korean Society of Pathologists/The Korean Society for Cytopathology http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Ahn, Soomin
Lee, Jae Jun
Ha, Sang Yun
Sung, Chang Ohk
Kim, Jhingook
Han, Joungho
Clinicopathological Analysis of 21 Thymic Neuroendocrine Tumors
title Clinicopathological Analysis of 21 Thymic Neuroendocrine Tumors
title_full Clinicopathological Analysis of 21 Thymic Neuroendocrine Tumors
title_fullStr Clinicopathological Analysis of 21 Thymic Neuroendocrine Tumors
title_full_unstemmed Clinicopathological Analysis of 21 Thymic Neuroendocrine Tumors
title_short Clinicopathological Analysis of 21 Thymic Neuroendocrine Tumors
title_sort clinicopathological analysis of 21 thymic neuroendocrine tumors
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479770/
https://www.ncbi.nlm.nih.gov/pubmed/23110006
http://dx.doi.org/10.4132/KoreanJPathol.2012.46.3.221
work_keys_str_mv AT ahnsoomin clinicopathologicalanalysisof21thymicneuroendocrinetumors
AT leejaejun clinicopathologicalanalysisof21thymicneuroendocrinetumors
AT hasangyun clinicopathologicalanalysisof21thymicneuroendocrinetumors
AT sungchangohk clinicopathologicalanalysisof21thymicneuroendocrinetumors
AT kimjhingook clinicopathologicalanalysisof21thymicneuroendocrinetumors
AT hanjoungho clinicopathologicalanalysisof21thymicneuroendocrinetumors